Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Buy
66
DNB Quote, Financials, Valuation and Earnings
Last price:
$8.96
Seasonality move
:
-0.72%
Day range:
$8.93 - $8.96
52-week range:
$7.78 - $12.95
Dividend yield:
2.24%
P/E ratio:
--
P/S ratio:
1.63x
P/B ratio:
1.20x
Volume:
75.7M
Avg. volume:
22.5M
1-year change:
-4.48%
Market cap:
$4B
Revenue:
$2.4B
EPS (TTM):
-$0.06
Earnings Data
Next earnings date for DNB
May 01
2025
Most recent earnings per share
$0.02
Missed by $0.30
(Feb 20/2025)
Consensus Estimate
$0.32
(Feb 20/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DNB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $594.8M | -- | -- | $0.23 | -- |
| 05/01/2025 | Q1 | $578M | -- | -- | $0.20 | -- |
| 02/20/2025 | Q4 | $658M | $631.9M | $0.02 | $0.32 | -$0.30 |
| 10/31/2024 | Q3 | $605.6M | $609.1M | $0.01 | $0.27 | -$0.26 |
| 08/01/2024 | Q2 | $580.7M | $576.2M | -$0.04 | $0.23 | -$0.27 |
| 05/02/2024 | Q1 | $565.5M | $564.5M | -$0.05 | $0.20 | -$0.25 |
| 02/15/2024 | Q4 | $622.2M | $630.4M | $0.00 | $0.32 | -$0.31 |
| 11/01/2023 | Q3 | -- | -- | $0.01 | $0.26 | -$0.25 |
| 06/30/2023 | Q2 | -- | -- | -$0.04 | $0.21 | -$0.25 |
| 03/31/2023 | Q1 | -- | -- | -$0.08 | $0.19 | -$0.27 |
| 12/31/2022 | Q4 | -- | -- | $0.05 | $0.34 | -$0.29 |
| 09/30/2022 | Q3 | -- | -- | $0.02 | $0.30 | -$0.28 |
| 06/30/2022 | Q2 | -- | -- | -$0.00 | $0.25 | -$0.26 |
| 03/31/2022 | Q1 | -- | -- | -$0.07 | $0.23 | -$0.30 |
| 12/31/2021 | Q4 | -- | -- | -$0.03 | $0.30 | -$0.33 |
| 09/30/2021 | Q3 | -- | -- | $0.04 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.12 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.06 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | $0.02 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.04 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.52 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | $0.10 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.64 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.22 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.23 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.55 | -- | -- |
Dun & Bradstreet Holdings Earnings Questions
-
How Much did Dun & Bradstreet Holdings Generate in Revenue Last Quarter?
Dun & Bradstreet Holdings reported $631.9M worth of top line sales in its most recent quarter.
-
Did Dun & Bradstreet Holdings Beat Earnings Last Quarter?
Dun & Bradstreet Holdings announced earnings per share of $0.02 which represents a miss of analyst forecast a $0.32 per share.
-
Is Dun & Bradstreet Holdings Profitable?
Dun & Bradstreet Holdings reported $395.9M that represents $0.91 per share over the last quarter.
-
What is the Analyst Consensus for Dun & Bradstreet Holdings EPS Next Year?
Dun & Bradstreet Holdings's earnings are forecast to grow from -$0.07 per share to $1.01 per share next year representing an increase of --.
-
When is Dun & Bradstreet Holdings's Earnings Date?
Currently, Dun & Bradstreet Holdings has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on May 22, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
